All children who experience epileptic falls do not necessarily have Lennox-Gastaut syndrome... but many do

Epileptic Disorders

Volumn 13, Issue , 2011, Pages S3-S13

  Arzimanoglou, Alexis ^a,b,c   Resnick, Trevor ^d  

^a HOSPICES CIVILS DE LYON   (France)

^b LYON NEUROSCIENCE RESEARCH CENTER   (France)

^c UNIVERSITÉ LYON 1   (France)

^d MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

Atypical benign partial epilepsy; Differential diagnosis; Doose syndrome; Dravet syndrome; Lennox Gastaut syndrome; Myoclonic astatic seizures

Indexed keywords

ANTICONVULSIVE AGENT; STIRIPENTOL;

ABSENCE; ATONIC SEIZURE; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL ASSESSMENT; COGNITIVE DEFECT; DIFFERENTIAL DIAGNOSIS; DROP ATTACK; EARLY DIAGNOSIS; EEG ABNORMALITY; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FOCAL EPILEPSY; HUMAN; INFANTILE SPASM; LENNOX GASTAUT SYNDROME; MYOCLONIC ASTATIC EPILEPSY; MYOCLONUS SEIZURE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEVERE MYOCLONIC EPILEPSY IN INFANCY; TONIC SEIZURE; MENTAL DEFICIENCY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; SEIZURE;

CHILD; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; HUMANS; MENTAL RETARDATION; PRACTICE GUIDELINES AS TOPIC; SEIZURES; SPASMS, INFANTILE;

EID: 80052575585     PISSN: 12949361     EISSN: 19506945     Source Type: Journal    
DOI: 10.1684/epd.2011.0422     Document Type: Review

References (59)

1. Aicardi J, Chevrie JJ. Myoclonic epilepsiesofchildhood. Neuropadiatrie 1971;3:177-90.
2. Aicardi J, Gomes AL. Clinical and EEG symptomatology of the "genuine" Lennox-Gastaut syndrome and its differentiation from other forms of epilepsy in early childhood. In: Degen R, ed. The benign localized and generalized epilepsies of early childhood. Amsterdam: Elsevier, 1992:185-93.
3. Arts WF, Geerts AT. When to start drug treatment for childhood epilepsy: the clinical-epidemiological evidence. Eur J Paediatr Neurol 2009;13:93-101.
4. Arzimanoglou A, Guerrini R, Aicardi J. Lennox-Gastaut syndrome. In: Aicardi's Epilepsy in Children, 3rd edition. Philadelphia: Lippincott Williams & Wilkins, 2004a, 38-50.
5. rd edition. Philadelphia: Lippincott Williams & Wilkins, 2004b, 58-80.
6. Arzimanoglou A. Dravet syndrome: from electroclinical characteristics to molecular biology. Epilepsia 2009;50(Suppl. 8):3-9.
7. Arzimanoglou A, French J, Blume WT, et al. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 2009;8:82-93.
8. Bauer G, Aichner F, Saltuari L. Epilepsies with diffuse slow spikes and waves of late onset. Eur Neurol 1983;22:344-50.
9. Beaumanoir A. The Lennox-Gastaut Syndrome. In: Roger J, Bureau M, Dravet C, et al, eds. Epileptic syndromes in infancy, childhood and adolescence. London: John Libbey, 1985:89-99.
10. Beaumanoir A, Dravet C. The Lennox-Gastaut syndrome. In: Roger J, Bureau M, Dravet C, et al, eds. Epileptic syndromes in infancy, childhood and adolescence. London: John Libbey, 1992:115-32.
11. Blume WT, Lüders HO, Mizrahi E, Tassinari C, van Emde Boas W, Engel J Jr. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001;42:1212-8.
12. Camfield P, Camfield C. Epileptic syndromes in childhood: clinical features, outcomes, and treatment. Epilepsia 2002;43(Suppl. 3):27-32.
13. Campos-Castelló J. Lennox-Gastaut syndrome. Orphanet Encyclopedia. September 2004. Available at: http://www.orpha.net/data/patho/GB/uk-Lennox.pdf. Accessed 16 December 2010.
14. Cavazzuti GB. Epidemiology of different types of epilepsy in school age children of Modena, Italy. Epilepsia 1980;21:57-62.
15. Chevrie JJ, Aicardi J. Childhood epileptic encephalopathy with slow spike-wave. A statistical study of 80 cases. Epilepsia 1972;13:259-71.
16. Chiron C. Stiripentol. Neurotherapeutics 2007;4:123-5.
17. Chiron C, Marchand MC, Tran A, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebocontrolled syndrome-dedicated trial, STICLO study group. Lancet 2000;356:1638-42.
18. Chiron C, Tonnelier S, Rey E, et al. Stiripentol in childhood partial epilepsy: randomized placebo-controlled trial with enrichment and withdrawal design. J Child Neurol 2006;21:496-502.
19. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001;68:1327-32.
20. Conry JA, Ng YT, Paolicchi JM, Kernitsky L, et al. Clobazam in the treatment of Lennox-Gastaut syndrome. Epilepsia 2009;50:1158-66.
21. Doose H. Myoclonic astatic epilepsy of early childhood. In: Roger J, Bureau M, Dravet CH, et al, eds. Epileptic syndromes in infancy, childhood and adolescence. 2nd edition. London: John Libbey & Company, 1992:103-14.
22. Dravet C. Les épilepsies graves de l'enfant. Vie Med 1978;8:543-8.
23. Dravet C, Roger J, Bureau M, Dalla Bernardina B. Myoclonic epilepsies in childhood. In: Akimoto H, Kazamatsuri H, Seino M, et al., eds. Advances in epileptology, XIIIth Epilepsy International Symposium. New York: Raven Press, 1982:135-40.
24. nd edition. London: John Libbey & Company, 1992:75-88.
25. rd ed. London: John Libbey, 2002:81-103.
26. Dulac O, N'Guyen T. The Lennox-Gastaut syndrome. Epilepsia 1993;34(Suppl. 7):S7-S17.
27. Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993;328:29-33.
28. Ferrie CD, Patel A. Treatment of Lennox-Gastaut Syndrome (LGS). Eur J Paediatr Neurol 2009;13:493-504.
29. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62:1261-73.
30. Gastaut H, Dravet C, Loubier D. Evolution clinique et pronostic du syndrome de Lennox-Gastaut. In: Lugaresi E, Pazzaglia P, Tassinari CA, eds. Evolution and prognosis of epilepsies. Bologna: Aulo Gaggi, 1973:133-54.
31. Genton P, Guerrini R, Dravet C. The Lennox-Gastaut syndrome. In: Meinardi H (ed). Handbook of Clinical Neurology, Vol 73(29): The Epilepsies, Part II. Amsterdam: Elsevier, 2000:211-22.
32. Geoffroy G, Lassonde M, Delisle F, Décarie M. Corpus callosotomy for control of intractable epilepsy in children. Neurology 1983;33:891-7.
33. Giovanardi-Rossi P, Gobbi G, Melideo G, et al. Myoclonic manifestations in the Lennox-Gastaut syndrome and other childhood epilepsies. In: Niedermeyer E, Degen R, eds. The Lennox-Gastaut syndrome. New York: Alan R. Liss, 1988:137-58.
34. Glauser TA. Following catastrophic epilepsy patients from childhood to adulthood. Epilepsia 2004;45(Suppl. 5):23-6.
35. Glauser T, Kluger G, Sachdeo R, Krauss G, Perdomo C, Arroyo S. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 2008;70:1950-8.
36. Glauser TA, Morita DA, Stannard KM. Lennox-Gastaut syndrome. eMedicine website 2010. Available at: http://emedicine.medscape.com/article/1176735-overview. Accessed 16 February 2011.
37. Guerrini R. Epilepsy in children. Lancet 2006;367:499-524.
38. Guerrini R, Belmonte A, Genton P. Antiepileptic druginduced worsening of seizures in children. Epilepsia 1998;39(Suppl. 3):S2-S10.
39. Hahn A. Atypical benign partial epilepsy/pseudo-Lennox syndrome. Epileptic Disord 2000;2(Suppl. 1):S11-S17.
40. Hoffmann-Riem M, Diener W, Benninger C, et al. Nonconvulsive status epilepticus - a possible cause of mental retardation in patients with Lennox-Gastaut syndrome. Neuropediatrics 2000;31:169-74.
41. Hughes JR, Patil VK. Long-term electro-clinical changes in the Lennox-Gastaut syndrome before, during, and after the slow spike-wave pattern. Clin Electroencephalogr 2002;33:1-7.
42. Inoue Y, Ohtsuka Y, Oguni H, et al. Stiripentol open study in Japanese patients with Dravet syndrome. Epilepsia 2009;50:2362-8.
43. International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989;30:389-99.
44. Kaminska A, Ickowicz A, Plouin P, Bru MF, Dellatolas G, Dulac O. Delineationofcryptogenic Lennox-Gastautsyndrome and myoclonic astatic epilepsy using multiple correspondence analysis. Epilepsy Res 1999;36:15-29.
45. Lipinski CG. Epilepsies with astatic seizures of late onset. Epilepsia 1977;18:13-20.
46. Liu S, An N, Yang H, et al. Pediatric intractable epilepsy syndromes: reason for early surgical intervention. Brain Dev 2007;29:69-78.
47. Markand ON. Lennox-Gastaut syndrome (childhood epileptic encephalopathy). J Clin Neurophysiol 2003;20:426-41.
48. Motte J, Trevathan E, Arvidsson JF, et al. Lamotrigine for generalized seizuresassociatedwiththe Lennox-Gastautsyndrome. N Engl J Med 1997;337:1807-12.
49. Oguni H, Fukuyama Y, Tanaka T, et al. Myoclonic-astatic epilepsy of early childhood-clinical and EEG analysis of myoclonic-astatic seizures, and discussions on the nosology of the syndrome. Brain Dev 2001;23:757-64.
50. Ohtsuka Y, Amano R, Mizukawa M, Ohtahara S. Long-term prognosis of the Lennox-Gastaut syndrome. Jpn J Psychiatry Neurol 1990;44:257-64.
51. Roger J, Dravet C, Bureau M. The Lennox-Gastaut syndrome. Cleve Clin J Med 1989;56(Suppl Pt 2):S172-S180.
52. Sachdeo RC, Glauser TA, Ritter F, et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 1999;52:1882-7.
53. Shields WD. Diagnosis of infantile spasms, Lennox-Gastaut syndrome, and progressive myoclonic epilepsy. Epilepsia 2004;45(Suppl. 5):2-4.
54. Sidenvall R, Forsgren L, Heijbel J. Prevalence and characteristics of epilepsy in children in northern Sweden. Seizure 1996;5:139-46.
55. Stafstrom CE. Updateon the management of Lennox-Gastaut syndrome with a focus on rufinamide. Neuropsychiatr Dis Treat 2009;5:547-51.
56. Thanh TN, Chiron C, Dellatolas G, et al. Long-term efficacy and tolerance of stiripentol in severe myoclonic epilepsy of infancy (Dravet's syndrome). Arch Pediatr 2002;9:1120-7.
57. Trevathan E, Murphy CC, Yeargin-Allsopp M. Prevalence and descriptive epidemiology of Lennox-Gastaut syndrome among Atlanta children. Epilepsia 1997;38:1283-8.
58. van Rijckevorsel K. Treatment of Lennox-Gastaut syndrome: overview and recent findings. Neuropsychiatr Dis Treat 2008;4:1001-19.
59. Wolff M, Cassé-Perrot C, Dravet C. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia 2006;47(Suppl. 2):45-8.